Risk of infection in MPN patients in the era of Covid-19: A prospective multicenter study of 257 patients from the CML-MPN Quebec Research Group

Kevin Simpson-Poirier; Michaël Harnois; Harold J Olney; Shireen Sirhan; Michel-Olivier Gratton; Sarit Assouline; Pierre Laneuville; Robert Delage; Luigina Mollica; Lambert Busque; Natasha Szuber

doi:10.1002/ajh.26159

Risk of infection in MPN patients in the era of Covid-19: A prospective multicenter study of 257 patients from the CML-MPN Quebec Research Group

Am J Hematol. 2021 Jun 1;96(6):E200-E203. doi: 10.1002/ajh.26159. Epub 2021 Mar 26.

Authors

Kevin Simpson-Poirier¹, Michaël Harnois², Harold J Olney^{1

2

3}, Shireen Sirhan^{2

4}, Michel-Olivier Gratton², Sarit Assouline^{2

4

5}, Pierre Laneuville^{2

6}, Robert Delage^{2

7}, Luigina Mollica^{1

2

8}, Lambert Busque^{1

2

8}, Natasha Szuber^{1

2

8}

Affiliations

¹ Université de Montréal, Montreal, Quebec, Canada.
² Groupe Québecois de Recherche sur la LMC et NMP (GQR LMC-NMP)/Chronic Myeloid Leukemia and Myeloproliferative Neoplasms Quebec Research Group, Montreal, Quebec, Canada.
³ Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
⁴ Segal Cancer Center, Jewish General Hospital, Montreal, Quebec, Canada.
⁵ Department of Oncology, McGill University, Montreal, Quebec, Canada.
⁶ McGill University Health Centre, Montreal, Quebec, Canada.
⁷ University of Quebec Center of Hematology and Oncology, Quebec, Quebec, Canada.
⁸ Division of Hematology, Hôpital Maisonneuve-Rosemont, Montreal, Quebec, Canada.

No abstract available

Publication types

Letter
Multicenter Study

MeSH terms

Adult
Aged
Aged, 80 and over
COVID-19 / etiology*
Communicable Diseases / etiology*
Female
Humans
Male
Middle Aged
Myeloproliferative Disorders / complications*
Polycythemia Vera / complications
Primary Myelofibrosis / complications
Prospective Studies
Quebec / epidemiology
Risk Factors
Thrombocythemia, Essential / complications